Experimental studies of the action of methylprednisolone acetate (Depo-Medrol) in microcrystals on Walker Ca in the rat
Cerchiai, G.; Gusso, M.I.
Archivio "putti" di Chirurgia Degli Organi di Movimento 32: 399-406
1982
ISSN/ISBN: 0066-670X PMID: 7183293 Document Number: 196616
Document emailed within 1 workday
Related Documents
Scaglietti, O.; Marchetti, P.G.; Bartolozzi, P. 1978: Remote results of the topical effect of methylprednisolone acetate microcrystals in various skeletal lesions Archivio "putti" di Chirurgia Degli Organi di Movimento 29: 11-28Gottberg, L. 2007: Go away Depo-Medrol! Lakartidningen 104(11): 885
Waldman, S.D. 1991: Notice of reformulation of Depo-Medrol by the Upjohn Company Regional Anesthesia 16(5): 300-301
Kruglova, G.V.; Poddubnaia, I.V.; Finogenova, I.A. 1994: The use of a daily dose of methylprednisolone (Medrol) once in treating hemoblastoses Terapevticheskii Arkhiv 66(7): 56-58
Philips, R.H.; Kulesza, M. 1995: Retinal detachment after accidental intra-vitreous Depo-Medrol injection. A case report Klinika Oczna 97(3-4): 82-85
Jeppsson, S. 1972: Experience with depo-medroxyprogesterone acetate (Depo-Provera) as a contraceptive agent Acta Obstetricia et Gynecologica Scandinavica 51(3): 257-263
Jeppsson, S. 1972: Experience with depo-medroxyprogesterone acetate (Depo-Provera) as a contraceptive agent Acta Obstetricia et Gynecologica Scandinavica 51(3): 257-263
Jeppsson, S. 1972: Experience with depo-medroxyprogesterone acetate (Depo-Provera) as a contraceptive agent Acta Obstetricia et Gynecologica Scandinavica 51(3): 257-263
Jeppsson, S.; Gershagen, S.; Johansson, E. D. B.; Rannevik, G. 1982: Plasma levels of medroxyprogesterone acetate (MPA), sex-hormone binding globulin, gonadal steroids, gonadotrophins and prolactin in women during long-term use of depo-MPA (Depo-Provera(R)) as a contraceptive agent European Journal of Endocrinology 99(3): 339-343
Moghissi, K.S.; Syner, F.N. 1975: Studies on the mechanism of action of continuous microdose quingestanol acetate Fertility and Sterility 26(8): 818-827
Powell, L.C.; Seymour, R.J. 1971: Effects of depo-medroxyprogesterone acetate as a contraceptive agent American Journal of Obstetrics and Gynecology 110(1): 36-41
Bloch, B. 1971: Depot medroxyprogesterone acetate (Depo-Provera) as a contraceptive preparation South African Medical Journal 45(28): 777-780
Soichet, S. 1969: Depo-provera (medroxyprogesterone acetate) as a female contraceptive agent International Journal of Fertility 14(1): 33-38
Cromer, B. 2005: In favor of continued use of depot medroxyprogesterone acetate (DMPA, Depo-Provera) in adolescents Journal of Pediatric and Adolescent Gynecology 18(3): 183-187
Omar, H.; Kives, S. 2005: Depot medroxyprogesterone acetate (DMPA, Depo-Provera) in adolescents: what is next after the FDA black box warning Journal of Pediatric and Adolescent Gynecology 18(3): 183
Cromer, B. 2005: In favor of continued use of depot medroxyprogesterone acetate (DMPA, Depo-Provera) in adolescents Journal of Pediatric and Adolescent Gynecology 18(3): 183-187
Omar, H.; Kives, S. 2005: Depot medroxyprogesterone acetate (DMPA, Depo-Provera) in adolescents: what is next after the FDA black box warning Journal of Pediatric and Adolescent Gynecology 18(3): 183
Ozgoli, G.; Sheikhan, Z.; Dolatian, M.; Simbar, M.; Bakhtyari, M.; Nasiri, M. 2015: Comparison of Sexual Dysfunction in Women Using Depo-Medroxyprogesterone Acetate (DMPA) and Cyclofem Journal of Reproduction and Infertility 16(2): 102-108
Omar, H.; Kives, S. 2005: Depot medroxyprogesterone acetate (DMPA, Depo-Provera) in adolescents: what is next after the FDA black box warning Journal of Pediatric and Adolescent Gynecology 18(3): 183
Cromer, B. 2005: In favor of continued use of depot medroxyprogesterone acetate (DMPA, Depo-Provera) in adolescents Journal of Pediatric and Adolescent Gynecology 18(3): 183-187